Department of Neurology and Neuroscience Institute, Christian Doppler Clinic, Paracelsus Medical University, Salzburg, Austria.
Sleep Med. 2010 Oct;11(9):870-5. doi: 10.1016/j.sleep.2010.05.007.
Although many animal and human studies have been performed, the exact mechanisms of action whereby modafinil promotes wakefulness are still not completely understood. We aimed to investigate the functional effects of modafinil on motor cortex excitability in patients with narcolepsy by means of transcranial magnetic stimulation (TMS) techniques.
In a double-blind and placebo-controlled design, 24 drug-naive narcoleptic patients with cataplexy and 20 control subjects were administered modafinil or placebo over a period of 4 weeks. TMS was performed twice during the awake state before and at the end of treatment; measures of cortical excitability included central motor conduction time, resting motor threshold, short latency intracortical inhibition (SICI) and intracortical facilitation to paired-TMS. TMS measures were correlated with the conventional neurophysiological method of Multiple Sleep Latency Test (MSLT) and the subjective Epworth Sleepiness Scale (ESS).
As previously reported, motor threshold and SICI were significantly increased in patients with narcolepsy; modafinil reversed this cortical hypoexcitability, but only SICI differences reached statistical significance. The Spearman rank correlation analysis revealed the highest correlation between SICI and the MSLT; a positive correlation was also found between SICI and the ESS, as well as between RMT and both measures of daytime sleepiness.
This represents the first report investigating effects of modafinil on cortical excitability in human narcolepsy. Since SICI is thought to be directly related to GABA(A) intracortical inhibitory activity, we demonstrated that the dose of modafinil that induces a satisfactory wakefulness-promoting response in narcoleptic patients also causes decrease in GABAergic transmission.
尽管已经进行了许多动物和人体研究,但莫达非尼促进觉醒的确切作用机制仍不完全清楚。我们旨在通过经颅磁刺激(TMS)技术研究莫达非尼对发作性睡病患者运动皮层兴奋性的功能影响。
在一项双盲、安慰剂对照设计中,24 名未经药物治疗的伴有猝倒的发作性睡病患者和 20 名对照者接受了为期 4 周的莫达非尼或安慰剂治疗。在治疗前和治疗结束时,在清醒状态下进行了两次 TMS 检查;皮层兴奋性的测量指标包括中枢运动传导时间、静息运动阈值、短潜伏期皮质内抑制(SICI)和对双 TMS 的皮质内易化。TMS 测量结果与传统的神经生理学方法多导睡眠潜伏期试验(MSLT)和主观嗜睡量表(ESS)相关。
正如先前报道的,发作性睡病患者的运动阈值和 SICI 显著升高;莫达非尼逆转了这种皮质兴奋性降低,但只有 SICI 的差异具有统计学意义。Spearman 秩相关分析显示 SICI 与 MSLT 相关性最高;SICI 与 ESS 之间以及 RMT 与日间嗜睡的两种测量指标之间也存在正相关。
这是首次报道莫达非尼对人类发作性睡病皮质兴奋性的影响。由于 SICI 被认为与 GABA(A)皮质内抑制活性直接相关,我们证明了诱导发作性睡病患者产生满意促醒作用的莫达非尼剂量也会导致 GABA 能传递减少。